Linee di indirizzo per la comunicazione in
Medicina di Genere
Documento approvato in seduta plenaria dall’Osservatorio dedicato alla Medicina di Genere...
Documento
·
Da
SOFIA ENRICA AMICARELLA
Alle
21 ago 23, 11:46
Linee di indirizzo per la comunicazione in
Medicina di Genere
Documento approvato in seduta plenaria dall’Osservatorio dedicato alla Medicina di Genere...
Documento
·
Da
Edoardo Di Matteo
Alle
6 nov 24, 11:09
Pag. 1 a 6
Istituto Superiore di Sanità
_____________________________
CONSIGLIO DI AMMINISTRAZIONE
DELIBERAZIONE N. 2
allegata al VERBALE n. 72 della seduta del CONSIGLIO DI...
Contenuto Web
·
Da
SIMONA DEODATI
Alle
22 dic 20, 17:43
Responsabile: Sonia D’Ilio Progettazione, modellazione, sviluppo e personalizzazione...: Marco Ferrari, Stefano Guderzo, Simona Deodati Esperti: Maria Alessandrelli,...
Come è la qualità
dell’informazione sul
controllo non farmacologico
della colesterolemia nel
nostro Paese?
• Gli acidi grassi omega-3, secondo molti
messaggi pubblicitari, abbassano la ...
Documento
·
Da
Edoardo Di Matteo
Alle
30 gen 26, 14:57
Anno di
riferimento
del
Pagamento
Trimestre
Categoria di
spesa
Tipologia di spesa Importo Beneficiario
2025 IV uscite correnti Acquisto di beni e di servizi 489,00...
Documento
·
Da
Stefano Pesarin
Alle
17 ott 25, 10:38
Anno di
riferimento
del
Pagamento
Trimestre
Categoria
di spesa
Tipologia di spesa Importo Beneficiario
2025 3
uscite
correnti
Contributi in conto
esercizio 9.116.104,25
...
Documento
·
Da
Edoardo Di Matteo
Alle
24 lug 25, 16:06
Anno di
riferimento
del
Pagamento
Trimestre
Categoria
di spesa
Tipologia di spesa Importo Beneficiario
2025 2
Uscite
c/capitale
Investimenti in beni
materiali 59.780,00...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
